Institutional Ownership
Pliant Therapeutics Inc
CUSIP 729139105COMPLRXQ1 2026
13D / 13G Filings
54
Schedule 13D/13G on record
Beneficial Filers
23
Distinct reporting persons
Largest Stake
16.5%
Max % of class reported
Institutional Holders
87
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
54 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Point72 Asset Management, L.P. | 13G/A | 0.1% | 46.5K | SEC |
| 2 | Feb 17, 2026 | Woodline Partners LP | 13G/A | 3.3% | 2.03M | SEC |
| 3 | Feb 9, 2026 | Citadel Advisors LLC | 13G | 5.0% | 3.04M | SEC |
| 4 | Jan 30, 2026 | Citadel Advisors LLC | 13G | 4.9% | 3.04M | SEC |
| 5 | Jan 22, 2026 | Citadel Advisors LLC | 13G | 4.9% | 2.99M | SEC |
| 6 | Jan 8, 2026 | Morgan Stanley | 13G/A | 0.9% | 545.2K | SEC |
| 7 | Nov 14, 2025 | Deep Track Capital, LP | 13G/A | — | — | SEC |
| 8 | Nov 14, 2025 | Woodline Partners LP | 13G | 7.3% | 4.50M | SEC |
| 9 | Sep 4, 2025 | Point72 Asset Management, L.P. | 13G | 6.7% | 4.09M | SEC |
| 10 | Aug 14, 2025 | Deep Track Capital, LP | 13G/A | 6.4% | 3.95M | SEC |
44 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Pliant Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Tang Capital Management LLC | 6.14M | $7.74M |
| 2 | Citadel Advisors LLC | 3.23M | $4.07M |
| 3 | Blue Owl Capital Holdings LP | 2.97M | $3.74M |
| 4 | Adar1 Capital Management, LLC | 2.59M | $3.26M |
| 5 | Two Sigma Investments, LP | 2.25M | $2.84M |
| 6 | Monaco Asset Management Sam | 1.94M | $2.44M |
| 7 | Renaissance Technologies LLC | 1.85M | $2.33M |
| 8 | Prosight Management, LP | 1.67M | $2.10M |
| 9 | Woodline Partners LP | 1.67M | $2.10M |
| 10 | Bml Capital Management, LLC | 1.55M | $1.95M |